Sign In
Buy TWST
$91.55
+0.220 (+0.241%)
At Close: Jul 31, 2026
Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) CEO Sells $1,204,149.60 in Stock
10:16am, Saturday, 20'th Nov 2021 Transcript Daily
Twist Bioscience Co. (NASDAQ:TWST) CEO Emily M. Leproust sold 10,440 shares of the stock in a transaction on Monday, November 15th. The stock was sold at an average price of $115.34, for a total transaction of $1,204,149.60. The sale was disclosed in a document filed with the SEC, which is available at this link. Emily []
What to expect with Twist Bioscience''s Q4 performance?
06:37pm, Friday, 19'th Nov 2021 Seeking Alpha
Twist Bioscience Corp (TWST) President & CEO Emily M. Leproust Sold $1.2 million of Shares
11:15pm, Wednesday, 17'th Nov 2021 GuruFocus
Related Stocks: TWST ,
Earnings Preview: Twist Bioscience (TWST) Q4 Earnings Expected to Decline
04:11pm, Monday, 15'th Nov 2021
Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AQR Capital Management LLC Increases Stake in Twist Bioscience Co. (NASDAQ:TWST)
11:36am, Sunday, 14'th Nov 2021 Dakota Financial News
AQR Capital Management LLC increased its position in Twist Bioscience Co. (NASDAQ:TWST) by 15.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 13,692 shares of the companys stock after acquiring an additional 1,801 shares during the quarter. AQR Capital Management LLCs holdings in Twist []
2 Stocks You'll Probably Never Want to Sell
09:01am, Sunday, 17'th Oct 2021
Both are biotech stocks with tremendous long-term opportunities.
Centogene, Twist Join Forces For Custom Test Kits For Rare Diseases
03:49pm, Wednesday, 06'th Oct 2021
Centogene NV (NASDAQ: CNTG) and Twist Bioscience Corporation (NASDAQ: TWST) have signed a contract to develop and commercialize custom assay kits for rare diseases. The financial details of the deal w
Twist Stock: Manufacturing The Future
04:20pm, Tuesday, 05'th Oct 2021
Twist Bioscience is a synthetic biology company that is able to produce DNA at significantly lower costs than competitors.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST) today reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent bind
Buying This Beaten-Down ETF Could Double Your Money Over the Next 5 Years
05:52am, Thursday, 23'rd Sep 2021
It could perhaps deliver a much bigger gain than 100%.
2 Biotech Stocks to Buy Right Now
09:31am, Sunday, 19'th Sep 2021
They both have great growth prospects.
Twist Bioscience, Boehringer Ingelheim Joins Forces For Antibody Research Programs
10:52am, Thursday, 09'th Sep 2021
Twist Bioscience Corporation (NASDAQ: TWST) has announced a broad-based research collaboration with Boehringer Ingelheim International GmbH. The collaboration will use Twist's proprietary antibody
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
09:56am, Thursday, 09'th Sep 2021
SOUTH SAN FRANCISCO, Calif. & INGELHEIM, Germany--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ:TWST), a company enabling customers to succeed through its offering of high-quality synthetic DN
Twist Bioscience to Present at Baird 2021 Global Healthcare Conference
08:00am, Wednesday, 08'th Sep 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon
Twist Bioscience, SomaLogic Team Up For Antibodies, Target Discovery
12:15pm, Wednesday, 18'th Aug 2021
Twist Bioscience Corporation (NASDAQ: TWST) and SomaLogic announced a partnership to discover novel therapeutic targets and antibodies. Financial and other details of the partnership were not disc
